Novartis’ oral Fabhalta (iptacopan) has been approved by the US Food and Drug Administration (FDA) as the first treatment for ...
A growing mistrust of medical providers could be traced back to doubts about scientific validity and treatment costs, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback